medroxyprogesterone acetate has been researched along with Polycystic Ovary Syndrome in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 9 (33.33) | 18.2507 |
| 2000's | 5 (18.52) | 29.6817 |
| 2010's | 8 (29.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, R; Gao, H; Huang, J; Kuang, Y; Lin, J; Lu, X; Xie, Q; Zhu, J | 1 |
| Jiang, S; Kuang, Y | 1 |
| Cai, R; Chen, Q; Fu, Y; Kuang, Y; Lu, X; Lyu, Q; Sun, L; Tian, H; Wang, Y; Ye, J | 1 |
| Chan, SS; Chung, JP; Chung, TK; Yiu, AK | 1 |
| Roemer, KL; Savaris, RF; Young, SL | 1 |
| Jeong, EG; Kim, ES; Seo, Y | 1 |
| Chen, H; Chen, Q; Kuang, Y; Lyu, Q; Wang, N; Wang, Y | 1 |
| Gezginç, K; Görkemli, H; Kiyici, A; Ozdemir, M; Ozdemir, S | 1 |
| Bagis, T; Haydardedeoglu, B; Kilicdag, EB; Simsek, E | 1 |
| Gada, D | 1 |
| Bozorgmanesh, M; Ghaderi, L; Jalilian, N; Modarresi, M; Rezaie, M | 1 |
| Bagis, T; Gokcel, A; Haydardedeoglu, B; Kilicdag, EB; Tarim, E; Zeyneloglu, HB | 1 |
| Abulatta, M; Badawy, A; Inany, H; Mosbah, A | 1 |
| Soler, NG; Wortsman, J | 1 |
| Raj, SG; Talbert, LM | 1 |
| Murphy, J; Singh, KB; Wortsman, J | 1 |
| Oliver, I; Pienkowski, C; Pigeon, P; Rochiccioli, P; Tauber, MT | 1 |
| Ajossa, S; Cagnacci, A; Melis, GB; Mulas, P; Orrù, M; Paoletti, AM; Pittorra, G; Soldani, R | 1 |
| Anttila, L; Erkkola, R; Irjala, K; Koskinen, P; Ruutiainen, K | 1 |
| Faure, N; Lemay, A | 1 |
| Abdul-Malak, ME; Morcos, RN; Shikora, E | 1 |
| Cunningham, SK; Fiad, TM; McKenna, TJ | 1 |
| Lane, G; Martin-Hirsch, P; Salha, O; Sharma, V | 1 |
| Dgani, R; Fenig, E; Open, M; Shani, A; Vinker, S | 1 |
| Anttila, L; Erkkola, R; Irjala, K; Kaihola, HL; Koskinen, P; Ruutiainen, K | 1 |
| Berga, SL; Yen, SS | 1 |
| Anderson, DC; Petsos, P; Ratcliffe, WA | 1 |
1 review(s) available for medroxyprogesterone acetate and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Polycystic ovarian disease.
Topics: Adrenal Hyperplasia, Congenital; Androgens; Chorionic Gonadotropin; Cimetidine; Clomiphene; Contraceptive Agents, Female; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Spironolactone | 1984 |
9 trial(s) available for medroxyprogesterone acetate and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cross-Over Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Severity of Illness Index; Testosterone; Young Adult | 2014 |
Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Embryo Transfer; Female; Fertilization; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Prospective Studies; Sperm Injections, Intracytoplasmic | 2016 |
Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgens; Androstenes; Carbohydrate Metabolism; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Lipid Metabolism; Luteinizing Hormone; Medroxyprogesterone Acetate; Menstrual Cycle; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2008 |
Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Body Mass Index; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Female; Follow-Up Studies; Homeostasis; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Medroxyprogesterone Acetate; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2009 |
Phytotherapeutic management of polycystic ovary syndrome: role of aerial parts of wood betony (Stachys lavandulifolia).
Topics: Adolescent; Adult; Female; Humans; Linear Models; Medroxyprogesterone Acetate; Phytotherapy; Plant Components, Aerial; Polycystic Ovary Syndrome; Stachys; Uterine Hemorrhage; Young Adult | 2013 |
The effects of short-term medroxyprogesterone acetate and micronized progesterone on glucose metabolism and lipid profiles in patients with polycystic ovary syndrome: a prospective randomized study.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Blood Glucose; Body Mass Index; Cholesterol, LDL; Female; Homeostasis; Humans; Insulin; Insulin Resistance; Lipids; Lipoprotein(a); Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Progesterone; Prospective Studies; Testosterone | 2002 |
Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a novel protocol.
Topics: Abortion, Spontaneous; Adult; Clomiphene; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Estradiol; Female; Fertility Agents, Female; Humans; Infertility, Female; Luteal Phase; Medroxyprogesterone Acetate; Ovulation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Progesterone; Prospective Studies; Treatment Outcome; Young Adult | 2009 |
Serum testosterone, androstenedione and luteinizing hormone levels after short-term medroxyprogesterone acetate treatment in women with polycystic ovarian disease.
Topics: Adult; Androstenedione; Female; Finland; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Oligomenorrhea; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 1994 |
Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy.
Topics: Adolescent; Adult; Estrogen Replacement Therapy; Female; Hair; Hirsutism; Humans; Leuprolide; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Testosterone | 1994 |
17 other study(ies) available for medroxyprogesterone acetate and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study.
Topics: Adult; Cohort Studies; Dydrogesterone; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Medroxyprogesterone Acetate; Ovulation Induction; Polycystic Ovary Syndrome; Progestins; Retrospective Studies; Young Adult | 2019 |
Clomiphene citrate is associated with favorable cycle characteristics but impaired outcomes of obese women with polycystic ovarian syndrome undergoing ovarian stimulation for in vitro fertilization.
Topics: Academic Medical Centers; Adult; Clomiphene; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Infertility, Female; Medroxyprogesterone Acetate; Menotropins; Obesity; Oocytes; Ovulation Induction; Polycystic Ovary Syndrome; Retrospective Studies | 2017 |
Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles.
Topics: Adult; Embryo Implantation; Embryo Transfer; Female; Fertilization in Vitro; Gonadotropins; Humans; Infertility, Female; Luteinizing Hormone; Medroxyprogesterone Acetate; Menotropins; Middle Aged; Oocyte Retrieval; Oocytes; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Retrospective Studies; Sperm Injections, Intracytoplasmic | 2018 |
Characterization of GAB1 expression over the menstrual cycle in women with and without polycystic ovarian syndrome provides a new insight into its pathophysiology.
Topics: Adaptor Proteins, Signal Transducing; Adult; Case-Control Studies; Cell Line, Tumor; Down-Regulation; Endometrium; Epithelial Cells; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; Phosphorylation; Polycystic Ovary Syndrome; Signal Transduction; Young Adult | 2014 |
Cushing's syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome.
Topics: Adult; Antineoplastic Agents, Hormonal; Cushing Syndrome; Endometrial Neoplasms; Female; Humans; Hyperandrogenism; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome | 2015 |
Luteal-phase clomiphene citrate in PCOS.
Topics: Clomiphene; Drug Administration Schedule; Female; Fertility Agents, Female; Humans; Luteal Phase; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Pregnancy; Randomized Controlled Trials as Topic; Research Design | 2009 |
Abnormalities of fuel metabolism in the polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Body Weight; Cholesterol; Cholesterol, HDL; Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lipids; Lipoproteins, HDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 1982 |
Evidence for the hypothalamic origin of the polycystic ovary syndrome.
Topics: Female; Follicle Stimulating Hormone; Humans; Hypothalamic Diseases; Hypothalamo-Hypophyseal System; Hypothalamus; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prolactin; Testosterone | 1981 |
[Precocious puberty and polycystic ovarian syndrome: apropos of 13 cases].
Topics: Androgen Antagonists; Child; Cyproterone Acetate; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Puberty, Precocious; Testosterone | 1995 |
Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome.
Topics: Delayed-Action Preparations; Dopamine; Dopamine Antagonists; Estradiol; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Ovary; Polycystic Ovary Syndrome; Prolactin; Sulpiride | 1995 |
Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
Topics: Administration, Cutaneous; Adolescent; Adult; Androstenedione; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Medroxyprogesterone Acetate; Pilot Projects; Polycystic Ovary Syndrome; Progesterone; Testosterone; Uterine Hemorrhage | 1994 |
Role of progesterone deficiency in the development of luteinizing hormone and androgen abnormalities in polycystic ovary syndrome.
Topics: Androgens; Cohort Studies; Female; Gonadotropins; Hirsutism; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners; Prospective Studies; Reference Values | 1996 |
Endometrial carcinoma in a young patient with polycystic ovarian syndrome: first suspected at time of embryo transfer.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Embryo Transfer; Endometrial Neoplasms; Female; Fertilization in Vitro; Follow-Up Studies; Humans; Hysterectomy; Hysteroscopy; Medroxyprogesterone Acetate; Ovulation Induction; Polycystic Ovary Syndrome | 1997 |
Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Ovariectomy; Parity; Polycystic Ovary Syndrome; Radiotherapy, Adjuvant | 1999 |
Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries.
Topics: Adolescent; Adult; Androgens; Female; Gonadotropins, Pituitary; Humans; Medroxyprogesterone Acetate; Oligomenorrhea; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1992 |
Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
Topics: Adult; Androgens; Estrogens; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Naloxone; Periodicity; Polycystic Ovary Syndrome; Progesterone | 1989 |
Effects of medroxyprogesterone acetate in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovulation; Pituitary Hormone-Releasing Hormones; Polycystic Ovary Syndrome | 1986 |